These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11055989)

  • 1. Structural determinants of PIP(2) regulation of inward rectifier K(ATP) channels.
    Shyng SL; Cukras CA; Harwood J; Nichols CG
    J Gen Physiol; 2000 Nov; 116(5):599-608. PubMed ID: 11055989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of the ATP/phosphatidylinositol 4,5 diphosphate-binding site to a 39-amino acid region of the carboxyl terminus of the ATP-regulated K+ channel Kir1.1.
    Dong K; Tang L; MacGregor GG; Hebert SC
    J Biol Chem; 2002 Dec; 277(51):49366-73. PubMed ID: 12381730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cloned ATP-sensitive K channels by phosphorylation, MgADP, and phosphatidylinositol bisphosphate (PIP(2)): a study of channel rundown and reactivation.
    Ribalet B; John SA; Weiss JN
    J Gen Physiol; 2000 Sep; 116(3):391-410. PubMed ID: 10962016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylinositol-4,5-bisphosphate, PIP2, controls KCNQ1/KCNE1 voltage-gated potassium channels: a functional homology between voltage-gated and inward rectifier K+ channels.
    Loussouarn G; Park KH; Bellocq C; Baró I; Charpentier F; Escande D
    EMBO J; 2003 Oct; 22(20):5412-21. PubMed ID: 14532114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfonylurea and K(+)-channel opener sensitivity of K(ATP) channels. Functional coupling of Kir6.2 and SUR1 subunits.
    Koster JC; Sha Q; Nichols CG
    J Gen Physiol; 1999 Aug; 114(2):203-13. PubMed ID: 10435998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol 4,5-bisphosphate (PIP2) modulation of ATP and pH sensitivity in Kir channels. A tale of an active and a silent PIP2 site in the N terminus.
    Schulze D; Krauter T; Fritzenschaft H; Soom M; Baukrowitz T
    J Biol Chem; 2003 Mar; 278(12):10500-5. PubMed ID: 12514171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
    Masia R; Enkvetchakul D; Nichols CG
    J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the ATP-sensitive K channel Kir6.2 by ATP and PIP(2).
    Ribalet B; John SA; Xie LH; Weiss JN
    J Mol Cell Cardiol; 2005 Jul; 39(1):71-7. PubMed ID: 15978904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotides and phospholipids compete for binding to the C terminus of KATP channels.
    MacGregor GG; Dong K; Vanoye CG; Tang L; Giebisch G; Hebert SC
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2726-31. PubMed ID: 11880626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the PIP2-binding site on Kir6.2 by molecular modelling and functional analysis.
    Haider S; Tarasov AI; Craig TJ; Sansom MS; Ashcroft FM
    EMBO J; 2007 Aug; 26(16):3749-59. PubMed ID: 17673911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cardiac inwardly rectifying potassium channels by membrane lipid metabolism.
    Takano M; Kuratomi S
    Prog Biophys Mol Biol; 2003 Jan; 81(1):67-79. PubMed ID: 12475570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of adenosine triphosphate-sensitive potassium channels by acyl coenzyme A esters involves multiple phosphatidylinositol 4,5-bisphosphate-interacting residues.
    Manning Fox JE; Nichols CG; Light PE
    Mol Endocrinol; 2004 Mar; 18(3):679-86. PubMed ID: 14694085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP-sensitive K+ channels: regulation of bursting by the sulphonylurea receptor, PIP2 and regions of Kir6.2.
    Ribalet B; John SA; Xie LH; Weiss JN
    J Physiol; 2006 Mar; 571(Pt 2):303-17. PubMed ID: 16373383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylinositol-4,5-bisphosphate (PIP2) regulation of strong inward rectifier Kir2.1 channels: multilevel positive cooperativity.
    Xie LH; John SA; Ribalet B; Weiss JN
    J Physiol; 2008 Apr; 586(7):1833-48. PubMed ID: 18276733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The carboxyl termini of K(ATP) channels bind nucleotides.
    Vanoye CG; MacGregor GG; Dong K; Tang L; Buschmann AS; Hall AE; Lu M; Giebisch G; Hebert SC
    J Biol Chem; 2002 Jun; 277(26):23260-70. PubMed ID: 11956191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipids as modulators of K(ATP) channels: distinct mechanisms for control of sensitivity to sulphonylureas, K(+) channel openers, and ATP.
    Krauter T; Ruppersberg JP; Baukrowitz T
    Mol Pharmacol; 2001 May; 59(5):1086-93. PubMed ID: 11306691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms for Kir channel inhibition by quinacrine: acute pore block of Kir2.x channels and interference in PIP2 interaction with Kir2.x and Kir6.2 channels.
    López-Izquierdo A; Aréchiga-Figueroa IA; Moreno-Galindo EG; Ponce-Balbuena D; Rodríguez-Martínez M; Ferrer-Villada T; Rodríguez-Menchaca AA; van der Heyden MA; Sánchez-Chapula JA
    Pflugers Arch; 2011 Oct; 462(4):505-17. PubMed ID: 21779761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of ROMK1 channel by protein kinase A via a phosphatidylinositol 4,5-bisphosphate-dependent mechanism.
    Liou HH; Zhou SS; Huang CL
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5820-5. PubMed ID: 10318968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic unsaturated free fatty acids inhibit ATP-dependent gating of the G protein-gated K(+) channel.
    Kim D; Pleumsamran A
    J Gen Physiol; 2000 Mar; 115(3):287-304. PubMed ID: 10694258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen inhibits inward rectifier K+ 2.x family of inward rectifier channels by interfering with phosphatidylinositol 4,5-bisphosphate-channel interactions.
    Ponce-Balbuena D; López-Izquierdo A; Ferrer T; Rodríguez-Menchaca AA; Aréchiga-Figueroa IA; Sánchez-Chapula JA
    J Pharmacol Exp Ther; 2009 Nov; 331(2):563-73. PubMed ID: 19654266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.